β-Amyloid (31-35) is the shortest sequence of native Amyloid-β peptide that retains neurotoxic activity.
CAT No: R1785
CAS No:149385-65-9
Synonyms/Alias:149385-65-9;H-ILE-ILE-GLY-LEU-MET-OH;AMYLOID Beta-PROTEIN (31-35);(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoic acid;beta-Amyloid (31-35);MFCD06659094;-Amyloid (31-35);??Amyloid (31-35);Isoleucinyl-isoleucinyl-glycinyl-leucinyl-methionine;CHEMBL272776;HY-P1517;DA-70829;FA109633;MS-30013;CS-0044618;G13359;Amyloid b-Protein (31-35) (H-Ile-Ile-Gly-Leu-Met-OH);
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More